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Abstract
Background: Sputum concentration increases the sensitivity of smear microscopy for the diagnosis of
tuberculosis (TB), but few studies have investigated this method in human immunodeficiency virus (HIV)-infected
individuals.
Methods: We performed a prospective, blinded evaluation of direct and concentrated Ziehl-Neelsen smear
microscopy on a single early-morning sputum sample in HIV-infected patients with > 2 weeks of cough
hospitalized in Kampala, Uganda. Direct and concentrated smear results were compared with results of
Lowenstein-Jensen culture.
Results: Of 279 participants, 170 (61%) had culture-confirmed TB. The sensitivity of direct and concentrated
smear microscopy was not significantly different (51% vs. 52%, difference 1%, 95% confidence interval (CI): [-7%,
10%], p = 0.88). However, when results of both direct and concentrated smears were considered together,
sensitivity was significantly increased compared with either method alone (64%, 95% CI: [56%, 72%], p < 0.01 for
both comparisons) and was similar to that of direct smear results from consecutive (spot and early-morning)
specimens (64% vs. 63%, difference 1%, 95% CI: [-6%, 8%], p = 0.85). Among 109 patients with negative cultures,
one had a positive direct smear and 12 had positive concentrated smears (specificity 99% vs. 89%, difference 10%,
95% CI: [2%, 18%], p = 0.003). Of these 13 patients, 5 (38%) had improved on TB therapy after two months.
Conclusion: Sputum concentration did not increase the sensitivity of light microscopy for TB diagnosis in this
HIV-infected population. Given the resource requirements for sputum concentration, additional studies using
maximal blinding, high-quality direct microscopy, and a rigorous gold standard should be conducted before
universally recommending this technique.
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Direct sputum smear microscopy is the cornerstone of
tuberculosis (TB) diagnosis worldwide [1]. Direct smear
microscopy is rapid, inexpensive [2-4], highly specific [5-
7], and capable of identifying the most infectious cases of
TB [7-9], but its sensitivity is limited, particularly in those
with human immunodeficiency virus (HIV) co-infection
[10-13]. Processing of sputum with subsequent concen-
tration by centrifugation or sedimentation may increase
the sensitivity of smear microscopy [14], and some inves-
tigators have recommended sputum processing and con-
centration as a global standard [15]. However, others have
called for more evidence before implementing such a pol-
icy change, citing concerns such as increased cost for
materials and training, higher biosafety requirements, and
difficulty standardizing techniques across sites [16]. Of
equally great concern, sputum concentration carries a risk
of decreased sensitivity (e.g., through destruction of
bacilli during concentration) [17,18] and specificity (e.g.,
through contamination during additional transfer steps)
[19,20]. In addition, the difficulty in blinding readers as
to whether a specimen is concentrated presents an inher-
ent risk of bias in studies of sputum concentration. Few
studies have employed the clear design and reporting
requirements required to minimize this inherent risk [21]
or evaluated sputum concentration in populations with
high HIV prevalence [22-26].
We therefore performed a prospective, blinded evaluation
of direct and concentrated smear microscopy – performed
simultaneously on a single early-morning sputum speci-
men – in a population of hospitalized, HIV-infected




Consecutive HIV-infected patients admitted to the medi-
cal wards of Mulago Hospital (Kampala, Uganda)
between September 2007 and April 2008 for respiratory
illness with cough of at least 2 weeks' duration were eligi-
ble for the study. We included patients who provided
informed consent and an early-morning sputum speci-
men for TB diagnosis. We excluded patients who were
receiving anti-TB treatment or had clinical evidence of
congestive heart failure. The study protocol was approved
by the institutional review boards at Makerere University,
Mulago Hospital, the Uganda National Council for Sci-
ences and Technology, and the University of California,
San Francisco.
Patient Evaluation
All patients were tested for HIV infection with a sequential
testing algorithm incorporating three rapid enzyme
immunoassay kits. For TB diagnosis, patients provided a
randomly-timed sputum sample for direct smear micros-
copy at the time of enrollment. In addition, patients pro-
vided an early-morning sputum sample on the morning
following admission; this sample was sent for both direct
and concentrated smear microscopy (as described below).
Patients without any positive smear examinations were
offered bronchoscopy with bronchoalveolar lavage (BAL)
if the procedure was deemed safe and appropriate by the
chest medicine consultant. All sputum and BAL speci-
mens were sent for mycobacterial culture. Patients with
suspected TB (determined by the treating ward physician)
began treatment with isoniazid, rifampin, ethambutol,
and pyrazinamide. Patients were evaluated during an out-
patient visit or by telephone interview between two and
four months after hospital discharge to assess for clinical/
radiographic improvement.
Laboratory Methods
Sputum and BAL samples were analyzed at the Uganda
National Tuberculosis and Leprosy Programme Reference
Laboratory (NTRL). Both direct and concentrated smears
were prepared from the same specimen. Direct smears
were prepared and stained using the hot Ziehl-Neelsen
method (1% carbol-fuchsin dye) [27]. Specimens were
then decontaminated with a 1% N-acetyl-L-cysteine
(NALC)-2% sodium hydroxide (NaOH)-2% sodium cit-
rate solution and concentrated by centrifugation at 3000
× g for 10 minutes [28]. The concentrated specimen was
then used to prepare mycobacterial cultures by inocula-
tion onto two separate Lowenstein-Jensen slants and, for
the early-morning specimen only, a concentrated smear
stained using the hot Ziehl-Neelsen method [29]. Con-
centrated smears were labeled with random identification
numbers immediately after preparation so that readers
could not determine if direct and concentrated smears
were from the same patient.
NTRL staff, who were also blinded to all clinical informa-
tion, read all smears within 48 hours of preparation using
a standard light microscope (magnification 1000×). They
reported the presence or absence of acid-fast bacilli (AFB)
using the WHO/IUATLD scale, with a positive result cor-
responding to ≥ 1 AFB per 100 high-power fields (HPFs)
[29]. They also read cultures weekly, designating as nega-
tive any slant with no growth after eight weeks of incuba-
tion. Positive cultures (defined as ≥ 1 colony forming
units) were confirmed with Ziehl-Neelsen staining. Study
staff promptly communicated all laboratory results to
ward physicians responsible for treatment decisions.
Since 2005, the Uganda NTRL has participated in a semi-
annual external quality assurance program for smear
microscopy administered by the World Health Organiza-
tion and has passed all quality assurance assessments.Page 2 of 9
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The primary outcome for our analyses was culture-posi-
tive TB, defined as a positive Lowenstein-Jensen (LJ) cul-
ture result from the randomly-timed sputum specimen,
early morning sputum specimen, or, when available, BAL
specimen. We performed two secondary analyses using
different "gold standard" definitions of TB. First, we
restricted the definition of TB to include only patients
with a positive culture on the same specimen from which
smears were prepared. Second, we broadened the defini-
tion of TB to also include patients who improved clini-
cally on empiric TB therapy, as documented by a study
medical officer and a chest consultant (W.W. or S.Y.)
between two and four months after hospital discharge.
Sample Size
We aimed to collect concentrated sputum specimens from
329 patients, in order to provide 90% power to detect a
difference between 50% and 60% sensitivity for direct and
concentrated sputum smear, respectively, assuming a 2-
sided alpha of 0.05, phi (correlation coefficient) of 0.5,
and a projected 20% dropout rate due to contamination
or failure to perform culture (i.e., final sample size of 262
patients). Sample size calculations were performed using
PS: Power and Sample Size Calculation, version 2.1.31
[30].
Statistical Analysis
Analyses were performed using STATA 9.0 (Stata Corp.,
College Station, TX). Sensitivity and specificity were calcu-
lated in reference to the outcomes defined above, and
compared between diagnostic strategies using McNemar's
test. Bivariate comparisons were made using Fisher's exact
test for dichotomous variables and the Wilcoxon rank-
sum test for continuous variables. Concordance was
measured using the kappa statistic. All p-values were two-
sided, with statistical significance defined as p < 0.05.
Results
Study Population
Of 388 eligible patients, 39 (10%) were unable to provide
an early-morning sputum specimen (unable or unwilling
to spontaneously expectorate), 20 (5%) did not have a
concentrated smear performed, 48 (12%) had a contami-
nated sputum culture, and 2 (1%) did not have culture
performed despite the availability of concentrated smear,
giving a final sample size of 279 HIV-infected TB suspects
(Figure 1). The majority of exclusions (other than for con-
tamination) occurred during a two-week period when the
NTRL lacked sufficient staffing to process research sam-
ples in addition to their routine clinical work. Patients
excluded from the study did not differ from those
included with regard to baseline characteristics (gender,
age, CD4 count, antiretroviral use) or the proportion of
TB cases confirmed by positive direct or concentrated
smear results (p > 0.15 for all comparisons). However,
excluded patients were more likely to die in the hospital
(28% vs. 8%, p < 0.001).
Of the 279 patients included in the study, 143 (51%) were
positive for TB on culture of the early-morning sputum
specimen used for comparison of direct and concentrated
smear results. An additional 27 (10%) were positive on
culture of another specimen. Of the remaining 109
patients, 103 (98%) had two or more negative cultures
and six had only a single negative culture. Exclusion of
these latter six patients did not materially affect results (all
had negative direct and concentrated smears). Patients
with at least one positive TB culture had significantly
lower CD4+ T-lymphocyte counts than patients with neg-
ative TB cultures (median 33 vs. 101, p < 0.0001), but
these two groups did not differ significantly by gender,
age, education, antiretroviral use, or by mortality at hospi-
tal discharge or at two months (Table 1). Regarding spu-
tum quality, of the 279 specimens, 33 (12%) were
described as salivary, 191 (68%) mucoid, 41 (15%) puru-
lent, and 14 (5%) bloody. Exclusion of salivary specimens
or restriction to mucoid specimens reduced the sample
size but did not materially affect results.
Sensitivity and Specificity of Direct and Concentrated 
Sputum Smear Microscopy
As shown in Table 2, the sensitivity of direct and concen-
trated smear microscopy was similar when using any pos-
itive culture result as the gold standard (51% vs. 52%,
difference 1%, 95% confidence interval: [-7%, 10%], p =
0.88). However, concordance between the two methods
was only fair, both among all specimens (80% overall
agreement; unweighted kappa 0.56, 95% CI: [0.44, 0.68])
and among culture-positive specimens (75% overall
agreement; unweighted kappa 0.51, 95% CI: [0.35,
0.66]). As a result, the performance of both smear tech-
niques on the same specimen yielded an absolute increase
of 12–13% in sensitivity over either smear alone (p < 0.01
for increase in sensitivity over direct or concentrated
smear alone). In addition, combining the results of direct
and concentrated smears of a single specimen had a simi-
lar sensitivity to performing direct smear microscopy on
two consecutive (randomly-timed and early-morning)
sputum specimens (64% vs. 63%, difference 1%, 95%
confidence interval: [-6%, 8%], p = 0.85). Among the 109
patients with negative cultures, one had a positive direct
smear (specificity 99%, 95% CI: [94%, 100%]), and 12
had positive concentrated smears (specificity 89%, 95%
CI: [81%, 95%], p = 0.003 for difference).
We performed two secondary analyses using different def-
initions for the gold standard. First, when we restricted the
gold standard definition to a positive culture result of the
same specimen from which smears were prepared, thePage 3 of 9
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similar (59% vs. 58%, p = 1.0), and the specificity of direct
smear remained higher than that of concentrated smear
(97% vs. 87%, p = 0.003). Second, when we expanded the
gold standard to include patients with negative cultures
but clinical response to TB therapy, the sensitivity of the
two methods remained similar (44% vs. 48%, p = 0.38).
However, the difference in specificity was no longer statis-
tically significant (92% vs. 99%, p = 0.07) because 5
(42%) of the 12 patients with positive concentrated
smears but negative cultures had documented clinical
improvement on TB therapy at 2-month follow-up (Table
3).
Density of Acid-Fast Bacilli
Table 4 compares the density of AFB on specimens from
patients with culture-confirmed TB. Of 170 confirmed TB
patients, 67 (39%) were positive on both direct and con-
centrated smear, 61 (36%) were negative on both, 20
(12%) were positive only on concentrated smear, and 22
(13%) were positive only on direct smear. Among 20
specimens that were positive only after concentration, 8
(40%) had 10 or more AFB per 100 HPF. By contrast,
among 22 specimens that were positive only on direct
smear, 19 (86%) had 10 or more AFB per 100 HPF.
Study Flow DiagramFigure 1
Study Flow Diagram.
279 Patients with Culture Results 
170 (61%)  Culture-positive 
109 (39%)  Culture-negative 
26 (24%)    Improved on TB therapy 
50 (13% ) Culture Result Unavailable 
48 (12%)  Contaminated 
  2   (1%)  Not performed 
329 Initial Cultures Evaluated 
59 (15% ) Smear  Result Unavailable 
39 (10%)  Sputum not submitted  
20 (5%)    Sputum not concentrated 
388 Consecutive HIV-Infected 
TB SuspectsPage 4 of 9
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Sputum concentration did not increase the sensitivity of
light microscopy for TB diagnosis in this prospective,
blinded evaluation of 279 hospitalized, HIV-infected
adults in Kampala, Uganda. Moreover, sputum concentra-
tion decreased specificity, though this difference was
attenuated when clinical response to TB therapy was con-
sidered in the gold standard. The performance of concen-
trated smear microscopy requires further evaluation
before recommending universal implementation of this
technique.
Our finding that sputum concentration prior to Ziehl-
Neelsen staining did not significantly increase sensitivity
for TB over direct smear microscopy differs from the
results of five prior studies that found higher sensitivity in
HIV-endemic populations after sputum concentration
[31-35]. This discrepancy may reflect differences in study
site (e.g., research versus field setting), patient population
(e.g., specially-selected outpatients versus consecutive
hospitalized patients), gold standard (e.g., multiple cul-
tures and follow-up data not routinely used versus used),
or study methodology (e.g., sodium hypochlorite and
sedimentation versus NALC-NaOH and centrifugation).
In addition, although many studies employed some form
of blinding, it is difficult to blind readers to processing
method (direct vs. concentrated) due to the different
appearance of unprocessed versus processed slides. This
imperfect blinding is known to influence the results of
sputum smear microscopy [36] and would be expected to
inflate measured sensitivity for concentrated smear.
Although we cannot exclude random chance or weak-
nesses in our study design as the explanation for our neg-
ative results, a number of additional considerations speak
to the veracity of our findings. First, our reported 52% sen-
sitivity of concentrated smear is similar to that in previous
studies of HIV-infected individuals (i.e., 50% [37], 52%
[38], and 54% [39]), suggesting that the discrepancy in
findings may reflect higher sensitivity of direct micros-
copy in the present study, rather than higher sensitivity of
concentrated microscopy in other studies. In addition, our
study incorporated several features that strengthen its
internal validity – consecutive enrollment of a relevant
population, clear description of included and excluded
patients, blinded reading of index and reference tests by
trained non-research staff, and a gold standard which
incorporated multiple culture results and follow-up
assessment [40,41]. Thus, while our findings differ from
those of previous studies, the present study provides
sound evidence that sputum concentration does not uni-
versally increase smear sensitivity among HIV-infected TB
suspects, and it suggests that provision of high-quality
direct microscopy may diminish the benefit of sputum
concentration.
In this study, direct and concentrated sputum smear had
surprisingly low concordance among patients with cul-
ture-confirmed TB (kappa = 0.51), even though both tech-
niques were performed on the same sputum specimen.
Although direct and concentrated smear microscopy had
similar sensitivities, they detected different patients: 39%
(42/109) of all smear-positive patients with culture-con-
firmed TB were only positive by a single method (Table
2). Although most prior studies [42,43] have found mod-
erate-to-high concordance between direct and concen-
trated smear, one earlier study [44] – also performed using
high-speed centrifugation in an African reference lab –
found results similar to those presented here (sensitivity
of 43% for direct smear, 44% for concentrated smear, and
55% for direct plus concentrated smear). Collection of a
single sputum specimen would reduce patient burden in
terms of number of visits to health care centers, and could
also decrease the delay between clinical presentation and
initiation of treatment. Given the similar sensitivity of
direct and concentrated smear microscopy also observed
in our study, future studies should investigate whether








Female gender, n (%) 166 (60) 98 (58) 68 (62) 0.46
Age, median (IQR) 34 (27–40) 33 (27–40) 34 (28–40) 0.88
Education beyond primary level, n (%) 97 (35) 61 (36) 36 (33) 0.70
CD4 count, median (IQR) (n = 274) 49 (15–169) 33 (12–115) 101 (31–219) < 0.0001
Antiretroviral use on admission, n (%) 42 (15) 24 (14) 18 (17) 0.37
Mortality, n (%)
In hospital (n = 279) 23 (8) 13 (8) 10 (9) 0.66
Two-month (n = 241) 65 (27) 43 (30) 22 (23) 0.30
Clinical presentation, n (%)
Fever/chills/sweats 262 (94) 158 (93) 104 (95) 0.45
Weight loss 265 (95) 167 (98) 98 (90) 0.003
Hemoptysis 68 (28) 31 (21) 37 (40) 0.001
IQR, interquartile rangePage 5 of 9
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Table 2: Sensitivity and Specificity of Concentrated and Direct Smear, By Reference Outcome
Concentrated Smear Result Direct Smear Result Total
Gold Standard: Sputum Culture
A. Sensitivity
Positive Negative
Positive 67 (39%) 22 (13%) 89 (52%)
Negative 20 (12%) 61 (36%) 81 (48%)
Total 87 (51%) 83 (49%) 170 (100%)
Sensitivity of Direct Smear = 0.51 (0.43–0.59)
Sensitivity of Concentrated Smear = 0.52 (0.44–0.61)
Sensitivity of Direct + Concentrated Smear = 0.64 (0.56–0.72)a, b
B. Specificity
Positive Negative
Positive 0 (0%) 12 (11%) 12 (11%)
Negative 1 (1%) 96 (88%) 97 (89%)
Total 1 (1%) 108 (99%) 109 (100%)
Specificity of Direct Smear = 0.99 (0.94–1.0)a
Specificity of Concentrated Smear = 0.89 (0.81–0.95)b
Specificity of Direct + Concentrated Smear = 0.88 (0.80–0.94)b
Gold Standard: Sputum Culture + Clinical Criteria
A. Sensitivity
Positive Negative
Positive 67 (34%) 27 (14%) 94 (48%)
Negative 20 (10%) 82 (42%) 102 (52%)
Total 87 (44%) 109 (56%) 196 (100%)
Sensitivity of Direct Smear = 0.44 (0.36–0.52)
Sensitivity of Concentrated Smear = 0.48 (0.40–0.56)
Sensitivity of Direct + Concentrated Smear = 0.58 (0.50–0.66)a, b
B. Specificity
Positive Negative
Positive 0 (0%) 7 (8%) 7 (8%)
Negative 1 (1%) 75 (90%) 76 (92%)
Total 1 (1%) 82 (99%) 83 (100%)
Specificity of Direct Smear = 0.99 (0.93–1.0)
Specificity of Concentrated Smear = 0.92 (0.83–0.97)
Specificity of Direct + Concentrated Smear = 0.90 (0.81–0.96)b
a p < 0.05 for comparison with concentrated smear alone
b p < 0.05 for comparison with direct smear alone
BMC Infectious Diseases 2009, 9(1):53 http://www.biomedcentral.com/1471-2334/9/53performing multiple direct smears on a single specimen
can substantially increase sensitivity for TB, avoiding the
need for multiple patient visits.
As with any evaluation of smear microscopy, this study
has certain limitations. First, our study was designed to
measure a clinically relevant difference between direct and
concentrated microscopy and was not powered to demon-
strate equivalence. However, our 95% confidence inter-
vals exclude more than a 10% absolute difference in
sensitivity between the two methods. Second, this study
was conducted in a national reference laboratory using
NALC-NaOH on early-morning specimens collected from
a population of HIV-infected, hospitalized patients. Thus,
our results may not fully generalize to other settings (e.g.,
peripheral laboratories, laboratories using alternative spu-
tum processing methods, non-HIV populations, and
healthier outpatient populations). Estimates of diagnostic
performance are known to vary between ambulatory and
hospital settings. However, the choice of study population
is less likely to impact a comparison between two diag-
nostic techniques. In addition, given the rigorous training
required of microscopists at the Uganda NTRL, it is
unlikely that laboratory inexperience explains the results
of the present study. Finally, in order to better replicate
actual test conditions, internal quality assurance was not
performed during the study period. Though we would not
expect reliability to differentially affect direct versus con-
centrated sputum smear results, we were unable to quan-
tify inter-reader and intra-reader agreement.
Conclusion
In conclusion, we failed to find a difference in sensitivity
between direct and concentrated sputum smear micros-
copy performed in a national reference laboratory serving
an HIV-infected hospitalized adult population. Before
widely recommending sputum concentration, additional
field evaluations that demonstrate benefit when incorpo-
rating strict blinding, high quality direct smear micros-
copy, and a clear gold standard are needed. Such studies
should also investigate whether simpler modifications
(e.g., parallel performance of multiple direct smears on a
single sputum specimen) can similarly increase sensitivity
and cost-effectiveness. Ultimately, modifications in smear
microscopy may increase the yield of TB diagnosis only
marginally, a possibility which emphasizes the need for
Table 3: Data on Patients with Positive Smears and Negative Cultures
Patient ID Admission CD4 
Count
Smear Resulta Final Diagnosis Treated for TB After 
Discharge?
Status 2 Months After 
Discharge
Direct Concentrated
1 31 1+ TB Yes Improved
2 193 1+ TB Yes Improved
3 196 1+ TB Yes Improved
4 398 Scanty TB Yes Improved
5 687 3+ TB Yes Improved
6 110 1+ Aspergillus Yes No Improvement
7 3 1+ PCP Died in hospital Dead
8 5 Scanty Bacterial Pneumonia No Improved
9b 12 Scanty Unknown Died in hospital Dead
10 31 1+ Unknown Died in hospital Dead
11 59 1+ Unknown Died in hospital Dead
12 81 Scanty Bacterial Pneumonia No Improved
13 399 1+ Unknown No No Improvement
TB, tuberculosis; PCP, Pneumocystis jirovecii pneumonia
a Scanty = 1–9 acid-fast bacilli (AFB) per 100 high-power fields (HPF), 1+ = 1–9 AFB per 10 HPF, 3+ = >10 AFB per HPF.
b Direct smear alone was positive; for other patients, the concentrated smear alone was positive.
Table 4: Density of Acid-Fast Bacilli (per 100 High-Power Fields) in Patients with Culture-Positive Tuberculosis
Direct Smear Result Total
Concentrated Smear Result 0 1–9 ≥ 10
0 61 3 19 83
1–9 12 2 2 16
≥ 10 8 7 56 71
Total 81 12 77 170Page 7 of 9
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nologies.
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